A new study finds children and teens with obesity or diabetes who take GLP-1 weight-loss medications experience significant improvements in many cardiometabolic risk factors, but long-term safety questions remain.

A new study finds women with obesity who lose weight before IVF have increased odds of getting pregnant, especially through natural conception.

In a new study, people lost twice as much weight on a diet with minimally processed foods compared to one with ultra-processed foods.

People who quit taking anti-obesity meds, including popular GLP-1 receptor agonists, may regain a significant amount of weight after eight weeks, a new study finds.

Patients with obesity who take GLP-1 receptor agonists in real-world settings lose significantly less weight than participants in randomized clinical trials, according to new research.

Overweight and obese adults who followed a 4:3 intermittent fasting plan dropped more pounds in one year than those who counted calories.

Hollow cheeks and sagging skin are driving more weight-loss patients to the plastic surgeon; a new survey finds.

A new study finds calorie labels make a small but potentially significant impact on food selection and calorie intake.

U.S. News & World Report, working with leading medical and nutrition experts, reveals a list of the best diets for overall health and specific conditions.

New study examines U.S. trends in body mass index and obesity and finds improving numbers, driven in part by GLP-1 weight-loss drugs.

New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.